إعلان
إعلان

QNRX

QNRX logo

Quoin Pharmaceuticals, Ltd. - ADR

12.19
USD
برعاية
-0.96
-7.34%
٠٩ يناير, ١٥:٥٨ UTC -5
مغلق
exchange

بعد الإغلاق

12.10

-0.08
-0.69%

تقارير أرباح QNRX

النسبة الإيجابية المفاجئة

QNRX تفوق 14 من 21 آخر التقديرات.

67%

التقرير التالي

بيانات التقرير القادم
١١ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$3.40
التغير الضمني من Q3 25 (Revenue/ EPS)
--
/
-49.33%
التغير الضمني من Q4 24 (Revenue/ EPS)
--
/
-72.24%

Quoin Pharmaceuticals, Ltd. - ADR earnings per share and revenue

On ٠٦ نوفمبر ٢٠٢٥, QNRX reported earnings of -6.71 USD per share (EPS) for Q3 25, missing the estimate of -5.07 USD, resulting in a -32.19% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -11.19% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 المحللين forecast an EPS of -3.40 USD, with revenue projected to reach -- USD, implying an نقصان of -49.33% EPS, and -- of --% in Revenue from the last quarter.
الأسئلة الشائعة
For Q3 2025, Quoin Pharmaceuticals, Ltd. - ADR reported EPS of -$6.71, missing estimates by -32.19%, and revenue of $0.00, 0% as expectations.
The stock price moved down -11.19%, changed from $9.65 before the earnings release to $8.57 the day after.
The next earning report is scheduled for ١١ مارس ٢٠٢٦.
Based on 5 المحللين, Quoin Pharmaceuticals, Ltd. - ADR is expected to report EPS of -$3.40 and revenue of -- for Q4 2025.
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان